FDA Clearance Tracker · P080004-S045
iSert Preloaded IOL System, IPure Preloaded IOL System
Last checked: Nov 20, 2026Latest source record: Jun 22, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2023
Approved
Time to decision
336 days
Received Jul 21, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080004-S045
- Device name
- iSert Preloaded IOL System, IPure Preloaded IOL System
- Applicant
- Hoya Surgical Optics, Inc.
- Applicant location
- Chino Hills, CA
- Received
- Jul 21, 2022
- Decided
- Jun 22, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P080004
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at HOYA Lamphun Ltd., 725 Moo 4, Tambol Banklang, Amphur Muagn, Lamphun 5100, Thailand. Manufacturing processes will be limited to lathe cutting through primary packaging, shipment to and from sterilizer, Siam Steri Service Co. LTD, secondary packaging, and distribution of intraocular lenses (IOLs) and injector cartridges.
Source documents
Other decisions for Hoya Surgical Optics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.